Semaglutide: A Promising Ally Against Alzheimer’s?
In a groundbreaking study, researchers at Case Western Reserve School of Medicine have identified a potential new benefit of semaglutide, a widely used diabetes and weight-loss drug. According to their findings, semaglutide may significantly reduce the risk of Alzheimer’s disease in individuals with type 2 diabetes (T2D), outperforming seven other anti-diabetic medications.
Alzheimer’s disease, a devastating brain disorder that erodes memory and cognitive abilities, affects nearly 7 million Americans aged 65 and older, as reported by the Alzheimer’s Association. Alarmingly, it claims more lives annually than breast and prostate cancer combined.
Published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, the study suggests that T2D patients taking semaglutide had a markedly lower risk of developing Alzheimer’s disease. This trend was consistent across various subgroups, regardless of obesity status, gender, or age.
Semaglutide, a glucagon-like peptide receptor (GLP-1R) agonist, is the active ingredient in popular medications like Wegovy and Ozempic. It works by reducing hunger and regulating blood sugar levels in T2D patients.
Under the leadership of Rong Xu, a professor of biomedical informatics, the research team analyzed three years of electronic health records from nearly one million U.S. patients with T2D. Their statistical approach, which mimicked a randomized clinical trial, revealed that patients prescribed semaglutide had a significantly lower risk of Alzheimer’s compared to those on other anti-diabetic medications.
According to the CDC, Alzheimer’s disease results in approximately 120,000 deaths annually, ranking as the seventh-leading cause of death in the United States.
“This new study provides real-world evidence for semaglutide’s potential impact on Alzheimer’s disease,” Xu stated. “While preclinical research has hinted at its protective effects against neurodegeneration and neuroinflammation, our findings suggest the need for further exploration through randomized clinical trials.”
Despite these promising results, the study’s limitations prevent researchers from drawing definitive causal conclusions. Xu emphasized the importance of continued research into semaglutide’s potential as a treatment for this debilitating condition, encouraging further investigation into alternative drugs.
For more information, please contact Patty Zamora at [email protected].
More Articles
Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!
Los Alamitos Race Course is facing its most serious crisis in years after 18 horses died in 2025, prompting regulators to warn the track that its racing license is at risk without immediate safety reforms. Following three catastrophic injuries in a single day, the California Horse Racing Board has ordered urgent changes—including more veterinarians, stricter medication rules, and enhanced on‑track medical support—as pressure mounts for stronger oversight in a sport already under national scrutiny.
Canadian investors have poured more than US$5.8 billion into U.S. commercial real estate this year, making the U.S. their top destination even amid a lingering tariff dispute. Tight inventory in Canada and greater deal availability south of the border are driving the trend, with data centers and industrial properties emerging as the hottest targets for 2025.
Florida’s insurance commissioner says even industry pros struggle to read today’s 150‑page homeowners policies—leaving residents shocked when hurricane claims are denied. With rising premiums, high replacement costs, and widespread confusion over exclusions like flood and water damage, the state is pushing for simpler, clearer policy language so homeowners know what they’re actually covered for before the next storm hits.
Following the 2025 elections, major metros like New York, Chicago, Miami, Los Angeles, and Boston are implementing policy shifts that could reshape property values, rental income, development timelines, and investment strategy heading into 2026. From New York’s push toward aggressive rent reform to Chicago’s sustainability mandates and Miami’s uncertain mayoral runoff, these changes signal a new era where local politics increasingly dictate market performance. This breakdown highlights the biggest post‑election real estate pivots and what they mean for investors, agents, and finance professionals preparing for a rapidly evolving landscape.
Florida’s Insurance Commissioner is sounding the alarm after thousands of homeowners discovered—only after hurricanes Helene and Milton—that the coverage they thought they had didn’t exist. With nearly 150,000 unpaid claims tied to misunderstood flood exclusions, water‑damage caps, and buried policy clauses, state leaders are pushing to simplify the dense, confusing documents most Floridians never read. As insurance costs remain one of the state’s top concerns, this growing complexity is creating a massive opportunity for real estate, mortgage, and insurance professionals to guide consumers before disaster strikes.
Florida’s insurance market is reliving an old crisis under a new name. Despite reforms meant to stabilize the system, homeowners are being forced out of Citizens and into pricier policies from small insurers with shaky financial histories. Companies tied to past insolvencies are returning with fresh branding, while highly rated carriers continue to deny a majority of claims. With political influence muddying regulation and climate risks rising, experts warn that only a full structural overhaul—not cosmetic reforms—can restore confidence for homeowners, agents, and the entire real estate market.
